Your browser doesn't support javascript.
Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB.
Imai, Masaki; Ito, Mutsumi; Kiso, Maki; Yamayoshi, Seiya; Uraki, Ryuta; Fukushi, Shuetsu; Watanabe, Shinji; Suzuki, Tadaki; Maeda, Ken; Sakai-Tagawa, Yuko; Iwatsuki-Horimoto, Kiyoko; Halfmann, Peter J; Kawaoka, Yoshihiro.
  • Imai M; University of Tokyo, Tokyo, Japan.
  • Ito M; University of Tokyo, Tokyo, Japan.
  • Kiso M; University of Tokyo, Tokyo, Japan.
  • Yamayoshi S; University of Tokyo, Tokyo, Japan.
  • Uraki R; University of Tokyo, Tokyo, Japan.
  • Fukushi S; National Institute of Infectious Diseases, Tokyo, Japan.
  • Watanabe S; National Institute of Infectious Diseases, Tokyo, Japan.
  • Suzuki T; National Institute of Infectious Diseases, Tokyo, Japan.
  • Maeda K; National Institute of Infectious Diseases, Tokyo, Japan.
  • Sakai-Tagawa Y; University of Tokyo, Tokyo, Japan.
  • Iwatsuki-Horimoto K; University of Tokyo, Tokyo, Japan.
  • Halfmann PJ; University of Wisconsin-Madison, Madison, WI.
  • Kawaoka Y; University of Tokyo, Tokyo, Japan yoshihiro.kawaoka@wisc.edu.
N Engl J Med ; 388(1): 89-91, 2023 01 05.
Article in English | MEDLINE | ID: covidwho-2147983
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / SARS-CoV-2 / COVID-19 / COVID-19 Drug Treatment Type of study: Prognostic study Topics: Variants Limits: Humans Language: English Journal: N Engl J Med Year: 2023 Document Type: Article Affiliation country: NEJMc2214302

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / SARS-CoV-2 / COVID-19 / COVID-19 Drug Treatment Type of study: Prognostic study Topics: Variants Limits: Humans Language: English Journal: N Engl J Med Year: 2023 Document Type: Article Affiliation country: NEJMc2214302